Pulse.

a daily field guide to health research that matters

◆ Console

‹ Wed · 11 Nov 2026
Standard addition

Active Surveillance of JAK2V617F Clonal Hematopoiesis Toward Myeloproliferative Neoplasms.

Catching early warning signs of blood-cell mutations before they develop into cancer allows treatment while disease is still minimal.

The study assessed whether active surveillance of JAK2V617F clonal hematopoiesis detects myeloproliferative neoplasms earlier. Surveillance-detected disease had lower variant allele frequency and less marrow fibrosis than referral-detected disease after a median 7.4 years to diagnosis.

What the study was

Study design
Prospective longitudinal surveillance cohort with retrospective baseline testing
Population
JAK2V617F-positive adults without myeloproliferative neoplasm at baseline
Sample size
92
Category
Early Detection
Maturity
Validated
Journal
Blood advances

Why it surfaced

Longitudinal population data support earlier hematologic disease detection, although the JAK2-positive surveillance cohort was modest

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.